Golimumab (anti-TNF monoclonal antibody): where we stand today-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Golimumab (anti-TNF monoclonal antibody): where we stand today

Published:2020-12-28 Issue:6 Volume:17 Page:1586-1598
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Melo Ana Teresa¹²,Campanilho-Marques Raquel¹²,Fonseca João Eurico¹²

Affiliation:

1. Rheumatology Department, Hospital De Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal

2. Rheumatology Research Unit, Instituto De Medicina Molecular João Lobo Antunes, Faculdade De Medicina, Universidade De Lisboa, Lisbon, Portugal

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1836919

Reference94 articles.

1. Golimumab for Rheumatoid Arthritis

2. Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α

3. TNFα blockade in human diseases: Mechanisms and future directions

4. Tumor necrosis factor inhibitors in psoriatic arthritis

5. Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studying protein–protein interactions: Latest and most popular approaches;Journal of Structural Biology;2024-12

2. Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019;Pharmacoepidemiology and Drug Safety;2024-08

3. Early identification of golimumab-treated patients with higher likelihood of long-term retention;Frontiers in Immunology;2024-04-05

4. Patient self-reported experience and satisfaction with golimumab and etanercept treatments for rheumatic diseases: A cohort study;Medicine;2024-02-23

5. Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases;Frontiers in Immunology;2024-01-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3